Leymen, France

Cara Brocklehurst

USPTO Granted Patents = 1 

Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):

Title: Discovering Innovations: The Contributions of Cara Brocklehurst

In the ever-evolving landscape of biotechnology, Cara Brocklehurst has carved a niche for herself through her innovative contributions as an inventor. Based in Leymen, France, she has been instrumental in advancing the field of medical research, particularly in the realm of protein interactions.

Latest Patents

Cara Brocklehurst holds a notable patent titled "Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors." This invention presents a compound of formula (I) or a pharmaceutically acceptable salt thereof, showcasing her expertise in developing new compounds with therapeutic potential.

Career Highlights

In her career, Cara has made significant strides working at Novartis AG, a global leader in the pharmaceutical industry. Her work focuses on developing innovative solutions that address critical challenges in healthcare and medicine. Alongside her patent achievements, she continues to contribute to groundbreaking projects that aim to enhance treatment options for various conditions.

Collaborations

Collaboration is a pivotal aspect of innovation, and Cara works closely with esteemed colleagues, including Vincent Bordas and Patrick Chene. Their combined expertise fosters a dynamic environment that encourages creative problem-solving and the pursuit of excellence in research and development.

Conclusion

Cara Brocklehurst stands out as a prominent inventor in the biotechnology sector, making substantial contributions through her patents and collaborative efforts. Her work at Novartis AG signifies the vital role of innovation in advancing medical science, paving the way for potential breakthroughs in patient care and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…